Cost-Effectiveness Analysis of Siltuximab for Australian Public Investment in the Rare Condition Idiopathic Multicentric Castleman Disease

por Shupo, Francis, Abrams, Keith R., Ademi, Zanfina, Wayi-Wayi, Grace, Zibelnik, Natasa, Kirchmann, Matt, Rutherford, Carolyn, Makarounas-Kirchmann, Kelly
Publicado 2023

PB2708: SYMPTOM BURDEN AND ITS IMPACT ON DAILY LIFE IN PATIENTS WITH IDIOPATHIC MULTICENTRIC CASTLEMAN’S DISEASE (IMCD): AN EXPLORATORY ANALYSIS OF THE SURVEY’S INTERNAL CONSTRUCT...

por Franklin, Matt, Shupo, Francis, Jones, Emily, Mason, Nicola, Wayi-Wayi, Grace, Kanhai, Karan, Zibelnick, Natasa, Repasky, Mileva, Makarounas-Kirchmann, Kelly, Mukherjee, Sudipto, Brazier, John
Publicado 2023